BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Doyle TJ, Washko GR, Fernandez IE, Nishino M, Okajima Y, Yamashiro T, Divo MJ, Celli BR, Sciurba FC, Silverman EK, Hatabu H, Rosas IO, Hunninghake GM; COPDGene Investigators. Interstitial lung abnormalities and reduced exercise capacity. Am J Respir Crit Care Med 2012;185:756-62. [PMID: 22268134 DOI: 10.1164/rccm.201109-1618OC] [Cited by in Crossref: 71] [Cited by in F6Publishing: 47] [Article Influence: 7.1] [Reference Citation Analysis]
Number Citing Articles
1 Podolanczuk AJ, Oelsner EC, Barr RG, Bernstein EJ, Hoffman EA, Easthausen IJ, Stukovsky KH, RoyChoudhury A, Michos ED, Raghu G, Kawut SM, Lederer DJ. High-Attenuation Areas on Chest Computed Tomography and Clinical Respiratory Outcomes in Community-Dwelling Adults. Am J Respir Crit Care Med 2017;196:1434-42. [PMID: 28613921 DOI: 10.1164/rccm.201703-0555OC] [Cited by in Crossref: 39] [Cited by in F6Publishing: 27] [Article Influence: 7.8] [Reference Citation Analysis]
2 Peacock AJ, Ling Y, Johnson MK, Kiely DG, Condliffe R, Elliot CA, Gibbs JSR, Howard LS, Pepke-Zaba J, Sheares KKK, Corris PA, Fisher AJ, Lordan JL, Gaine S, Coghlan JG, Wort SJ, Gatzoulis MA. Idiopathic pulmonary arterial hypertension and co-existing lung disease: is this a new phenotype? Pulm Circ 2020;10:2045894020914851. [PMID: 32284847 DOI: 10.1177/2045894020914851] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
3 Podolanczuk AJ, Oelsner EC, Barr RG, Hoffman EA, Armstrong HF, Austin JH, Basner RC, Bartels MN, Christie JD, Enright PL, Gochuico BR, Hinckley Stukovsky K, Kaufman JD, Hrudaya Nath P, Newell JD Jr, Palmer SM, Rabinowitz D, Raghu G, Sell JL, Sieren J, Sonavane SK, Tracy RP, Watts JR, Williams K, Kawut SM, Lederer DJ. High attenuation areas on chest computed tomography in community-dwelling adults: the MESA study. Eur Respir J 2016;48:1442-52. [PMID: 27471206 DOI: 10.1183/13993003.00129-2016] [Cited by in Crossref: 70] [Cited by in F6Publishing: 68] [Article Influence: 11.7] [Reference Citation Analysis]
4 Doyle TJ, Patel AS, Hatabu H, Nishino M, Wu G, Osorio JC, Golzarri MF, Traslosheros A, Chu SG, Frits ML, Iannaccone CK, Koontz D, Fuhrman C, Weinblatt ME, El-Chemaly SY, Washko GR, Hunninghake GM, Choi AM, Dellaripa PF, Oddis CV, Shadick NA, Ascherman DP, Rosas IO. Detection of Rheumatoid Arthritis-Interstitial Lung Disease Is Enhanced by Serum Biomarkers. Am J Respir Crit Care Med 2015;191:1403-12. [PMID: 25822095 DOI: 10.1164/rccm.201411-1950OC] [Cited by in Crossref: 75] [Cited by in F6Publishing: 45] [Article Influence: 10.7] [Reference Citation Analysis]
5 Stringer WW, Porszasz J, Bhatt SP, McCormack MC, Make BJ, Casaburi R. Physiologic Insights from the COPD Genetic Epidemiology Study. Chronic Obstr Pulm Dis 2019;6:256-66. [PMID: 31342731 DOI: 10.15326/jcopdf.6.3.2019.0128] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
6 Araki T, Nishino M, Zazueta OE, Gao W, Dupuis J, Okajima Y, Latourelle JC, Rosas IO, Murakami T, O'Connor GT, Washko GR, Hunninghake GM, Hatabu H. Paraseptal emphysema: Prevalence and distribution on CT and association with interstitial lung abnormalities. Eur J Radiol 2015;84:1413-8. [PMID: 25868675 DOI: 10.1016/j.ejrad.2015.03.010] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 4.0] [Reference Citation Analysis]
7 Liu Q, Zhang H, Han B, Jiang H, Chung KF, Li F. Interstitial lung abnormalities: What do we know and how do we manage? Expert Rev Respir Med 2021;15:1551-61. [PMID: 34689661 DOI: 10.1080/17476348.2021.1997598] [Reference Citation Analysis]
8 Doyle TJ, Dellaripa PF, Batra K, Frits ML, Iannaccone CK, Hatabu H, Nishino M, Weinblatt ME, Ascherman DP, Washko GR, Hunninghake GM, Choi AMK, Shadick NA, Rosas IO. Functional impact of a spectrum of interstitial lung abnormalities in rheumatoid arthritis. Chest 2014;146:41-50. [PMID: 24305643 DOI: 10.1378/chest.13-1394] [Cited by in Crossref: 45] [Cited by in F6Publishing: 39] [Article Influence: 5.6] [Reference Citation Analysis]
9 Buendia-Roldan I, Machuca N, Mejía M, Maldonado M, Pardo A, Selman M. Lower levels of α-Klotho in serum are associated with decreased lung function in individuals with interstitial lung abnormalities. Sci Rep 2019;9:10801. [PMID: 31346213 DOI: 10.1038/s41598-019-47199-0] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
10 Hatabu H, Hunninghake GM, Richeldi L, Brown KK, Wells AU, Remy-Jardin M, Verschakelen J, Nicholson AG, Beasley MB, Christiani DC, San José Estépar R, Seo JB, Johkoh T, Sverzellati N, Ryerson CJ, Graham Barr R, Goo JM, Austin JHM, Powell CA, Lee KS, Inoue Y, Lynch DA. Interstitial lung abnormalities detected incidentally on CT: a Position Paper from the Fleischner Society. Lancet Respir Med 2020;8:726-37. [PMID: 32649920 DOI: 10.1016/S2213-2600(20)30168-5] [Cited by in Crossref: 47] [Cited by in F6Publishing: 18] [Article Influence: 23.5] [Reference Citation Analysis]
11 Kawano-Dourado L, Doyle TJ, Bonfiglioli K, Sawamura MVY, Nakagawa RH, Arimura FE, Lee HJ, Rangel DAS, Bueno C, Carvalho CRR, Sabbag ML, Molina C, Rosas IO, Kairalla RA. Baseline Characteristics and Progression of a Spectrum of Interstitial Lung Abnormalities and Disease in Rheumatoid Arthritis. Chest 2020;158:1546-54. [PMID: 32428513 DOI: 10.1016/j.chest.2020.04.061] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 5.5] [Reference Citation Analysis]
12 Podolanczuk AJ, Putman RK. Clinical Relevance and Management of "Pre-Interstitial Lung Disease". Clin Chest Med 2021;42:241-9. [PMID: 34024400 DOI: 10.1016/j.ccm.2021.03.009] [Reference Citation Analysis]
13 Axelsson GT, Putman RK, Miller ER, Araki T, Sigurdsson S, Gudmundsson EF, Eiríksdottír G, Siggeirsdottir K, Aspelund T, Launer LJ, Harris TB, Hatabu H, Gudnason V, Hunninghake GM, Gudmundsson G. Interstitial lung abnormalities and physical function. ERJ Open Res 2018;4:00057-2018. [PMID: 30186845 DOI: 10.1183/23120541.00057-2018] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
14 Ash SY, Harmouche R, Putman RK, Ross JC, Diaz AA, Hunninghake GM, Onieva Onieva J, Martinez FJ, Choi AM, Lynch DA, Hatabu H, Rosas IO, San Jose Estepar R, Washko GR; COPDGene Investigators. Clinical and Genetic Associations of Objectively Identified Interstitial Changes in Smokers. Chest 2017;152:780-91. [PMID: 28506611 DOI: 10.1016/j.chest.2017.04.185] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]
15 Axelsson GT, Gudmundsson G. Interstitial lung abnormalities - current knowledge and future directions. Eur Clin Respir J 2021;8:1994178. [PMID: 34745461 DOI: 10.1080/20018525.2021.1994178] [Reference Citation Analysis]
16 Doyle TJ, Lee JS, Dellaripa PF, Lederer JA, Matteson EL, Fischer A, Ascherman DP, Glassberg MK, Ryu JH, Danoff SK, Brown KK, Collard HR, Rosas IO. A roadmap to promote clinical and translational research in rheumatoid arthritis-associated interstitial lung disease. Chest 2014;145:454-63. [PMID: 24590021 DOI: 10.1378/chest.13-2408] [Cited by in Crossref: 47] [Cited by in F6Publishing: 37] [Article Influence: 5.9] [Reference Citation Analysis]
17 Axelsson GT, Putman RK, Araki T, Sigurdsson S, Gudmundsson EF, Eiriksdottir G, Aspelund T, Miller ER, Launer LJ, Harris TB, Hatabu H, Gudnason V, Hunninghake GM, Gudmundsson G. Interstitial lung abnormalities and self-reported health and functional status. Thorax 2018;73:884-6. [PMID: 29317545 DOI: 10.1136/thoraxjnl-2017-210956] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
18 Chae KJ, Chung MJ, Jin GY, Song YJ, An AR, Choi H, Goo JM. Radiologic-pathologic correlation of interstitial lung abnormalities and predictors for progression and survival. Eur Radiol 2022. [PMID: 34984519 DOI: 10.1007/s00330-021-08378-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Ho JE, Gao W, Levy D, Santhanakrishnan R, Araki T, Rosas IO, Hatabu H, Latourelle JC, Nishino M, Dupuis J, Washko GR, O'Connor GT, Hunninghake GM. Galectin-3 Is Associated with Restrictive Lung Disease and Interstitial Lung Abnormalities. Am J Respir Crit Care Med 2016;194:77-83. [PMID: 26771117 DOI: 10.1164/rccm.201509-1753OC] [Cited by in Crossref: 36] [Cited by in F6Publishing: 18] [Article Influence: 7.2] [Reference Citation Analysis]
20 Pistenmaa CL, Washko GR. Computerized Chest Imaging in the Diagnosis and Assessment of the Patient with Chronic Obstructive Pulmonary Disease. Clin Chest Med 2020;41:375-81. [PMID: 32800192 DOI: 10.1016/j.ccm.2020.06.012] [Reference Citation Analysis]
21 Hoyer N, Thomsen LH, Wille MMW, Wilcke T, Dirksen A, Pedersen JH, Saghir Z, Ashraf H, Shaker SB. Increased respiratory morbidity in individuals with interstitial lung abnormalities. BMC Pulm Med 2020;20:67. [PMID: 32188453 DOI: 10.1186/s12890-020-1107-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
22 Hunninghake GM, Hatabu H, Okajima Y, Gao W, Dupuis J, Latourelle JC, Nishino M, Araki T, Zazueta OE, Kurugol S, Ross JC, San José Estépar R, Murphy E, Steele MP, Loyd JE, Schwarz MI, Fingerlin TE, Rosas IO, Washko GR, O'Connor GT, Schwartz DA. MUC5B promoter polymorphism and interstitial lung abnormalities. N Engl J Med 2013;368:2192-200. [PMID: 23692170 DOI: 10.1056/NEJMoa1216076] [Cited by in Crossref: 250] [Cited by in F6Publishing: 137] [Article Influence: 27.8] [Reference Citation Analysis]
23 Hino T, Lee KS, Han J, Hata A, Ishigami K, Hatabu H. Spectrum of Pulmonary Fibrosis from Interstitial Lung Abnormality to Usual Interstitial Pneumonia: Importance of Identification and Quantification of Traction Bronchiectasis in Patient Management. Korean J Radiol 2021;22:811-28. [PMID: 33543848 DOI: 10.3348/kjr.2020.1132] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
24 Wells AU, Kokosi MA. Subclinical Interstitial Lung Abnormalities: Toward the Early Detection of Idiopathic Pulmonary Fibrosis? Am J Respir Crit Care Med 2016;194:1445-6. [PMID: 27976940 DOI: 10.1164/rccm.201607-1363ED] [Cited by in Crossref: 21] [Cited by in F6Publishing: 7] [Article Influence: 4.2] [Reference Citation Analysis]
25 Putman RK, Hatabu H, Araki T, Gudmundsson G, Gao W, Nishino M, Okajima Y, Dupuis J, Latourelle JC, Cho MH, El-Chemaly S, Coxson HO, Celli BR, Fernandez IE, Zazueta OE, Ross JC, Harmouche R, Estépar RS, Diaz AA, Sigurdsson S, Gudmundsson EF, Eiríksdottír G, Aspelund T, Budoff MJ, Kinney GL, Hokanson JE, Williams MC, Murchison JT, MacNee W, Hoffmann U, O'Donnell CJ, Launer LJ, Harrris TB, Gudnason V, Silverman EK, O'Connor GT, Washko GR, Rosas IO, Hunninghake GM; Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) Investigators., COPDGene Investigators. Association Between Interstitial Lung Abnormalities and All-Cause Mortality. JAMA 2016;315:672-81. [PMID: 26881370 DOI: 10.1001/jama.2016.0518] [Cited by in Crossref: 226] [Cited by in F6Publishing: 192] [Article Influence: 37.7] [Reference Citation Analysis]
26 Mori Y, Kondoh Y. What parameters can be used to identify early idiopathic pulmonary fibrosis? Respir Investig 2021;59:53-65. [PMID: 33277230 DOI: 10.1016/j.resinv.2020.10.008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
27 Larsen TC, Gopalakrishnan V, Yao J, Nguyen CP, Chen MY, Moss J, Wen H. Optimization of a secondary VOI protocol for lung imaging in a clinical CT scanner. J Appl Clin Med Phys 2018;19:271-80. [PMID: 29785839 DOI: 10.1002/acm2.12354] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
28 Horst C, Gholipour B, Nair A, Jacob J. Differential diagnoses of fibrosing lung diseases. BJR Open 2019;1:20190009. [PMID: 33178941 DOI: 10.1259/bjro.20190009] [Cited by in Crossref: 3] [Article Influence: 1.0] [Reference Citation Analysis]
29 Ash SY, Harmouche R, Ross JC, Diaz AA, Rahaghi FN, Vegas Sanchez-Ferrero G, Putman RK, Hunninghake GM, Onieva Onieva J, Martinez FJ, Choi AM, Bowler RP, Lynch DA, Hatabu H, Bhatt SP, Dransfield MT, Wells JM, Rosas IO, San Jose Estepar R, Washko GR; COPDGene Investigators. Interstitial Features at Chest CT Enhance the Deleterious Effects of Emphysema in the COPDGene Cohort. Radiology 2018;288:600-9. [PMID: 29869957 DOI: 10.1148/radiol.2018172688] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 4.8] [Reference Citation Analysis]
30 Schwartz DA. Idiopathic Pulmonary Fibrosis Is a Genetic Disease Involving Mucus and the Peripheral Airways. Ann Am Thorac Soc 2018;15:S192-7. [PMID: 30431344 DOI: 10.1513/AnnalsATS.201802-144AW] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 6.3] [Reference Citation Analysis]
31 Putman RK, Gudmundsson G, Araki T, Nishino M, Sigurdsson S, Gudmundsson EF, Eiríksdottír G, Aspelund T, Ross JC, San José Estépar R, Miller ER, Yamada Y, Yanagawa M, Tomiyama N, Launer LJ, Harris TB, El-Chemaly S, Raby BA, Cho MH, Rosas IO, Washko GR, Schwartz DA, Silverman EK, Gudnason V, Hatabu H, Hunninghake GM. The MUC5B promoter polymorphism is associated with specific interstitial lung abnormality subtypes. Eur Respir J 2017;50:1700537. [PMID: 28893869 DOI: 10.1183/13993003.00537-2017] [Cited by in Crossref: 28] [Cited by in F6Publishing: 32] [Article Influence: 5.6] [Reference Citation Analysis]
32 Hunninghake GM. Interstitial lung abnormalities: erecting fences in the path towards advanced pulmonary fibrosis. Thorax 2019;74:506-11. [PMID: 30723182 DOI: 10.1136/thoraxjnl-2018-212446] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 5.3] [Reference Citation Analysis]
33 Sanders KJC, Ash SY, Washko GR, Mottaghy FM, Schols AMWJ. Imaging approaches to understand disease complexity: chronic obstructive pulmonary disease as a clinical model. J Appl Physiol (1985) 2018;124:512-20. [PMID: 28751367 DOI: 10.1152/japplphysiol.00143.2017] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
34 Choi B, Kawut SM, Raghu G, Hoffman E, Tracy R, Madahar P, Bernstein EJ, Barr RG, Lederer DJ, Podolanczuk A. Regional distribution of high-attenuation areas on chest computed tomography in the Multi-Ethnic Study of Atherosclerosis. ERJ Open Res 2020;6:00115-2019. [PMID: 32154292 DOI: 10.1183/23120541.00115-2019] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
35 Sanders JL, Putman RK, Dupuis J, Xu H, Murabito JM, Araki T, Nishino M, Benjamin EJ, Levy DL, Ramachandran VS, Washko GR, Curtis JL, Freeman CM, Bowler RP, Hatabu H, O'Connor GT, Hunninghake GM. The Association of Aging Biomarkers, Interstitial Lung Abnormalities, and Mortality. Am J Respir Crit Care Med 2021;203:1149-57. [PMID: 33080140 DOI: 10.1164/rccm.202007-2993OC] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
36 Lambert AA, Dransfield MT. COPD Overlap Syndromes: Asthma and Beyond. Chronic Obstr Pulm Dis 2016;3:459-65. [PMID: 28848867 DOI: 10.15326/jcopdf.3.1.2015.0176] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
37 Putman RK, Rosas IO, Hunninghake GM. Genetics and early detection in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2014;189:770-8. [PMID: 24547893 DOI: 10.1164/rccm.201312-2219PP] [Cited by in Crossref: 53] [Cited by in F6Publishing: 32] [Article Influence: 6.6] [Reference Citation Analysis]
38 Hino T, Lee KS, Yoo H, Han J, Franks TJ, Hatabu H. Interstitial lung abnormality (ILA) and nonspecific interstitial pneumonia (NSIP). Eur J Radiol Open 2021;8:100336. [PMID: 33796637 DOI: 10.1016/j.ejro.2021.100336] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
39 Hida T, Nishino M, Hino T, Lu J, Putman RK, Gudmundsson EF, Araki T, Valtchinov VI, Honda O, Yanagawa M, Yamada Y, Hata A, Jinzaki M, Tomiyama N, Honda H, Estepar RSJ, Washko GR, Johkoh T, Christiani DC, Lynch DA, Gudnason V, Gudmundsson G, Hunninghake GM, Hatabu H. Traction Bronchiectasis/Bronchiolectasis is Associated with Interstitial Lung Abnormality Mortality. Eur J Radiol 2020;129:109073. [PMID: 32480316 DOI: 10.1016/j.ejrad.2020.109073] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
40 Araki T, Putman RK, Hatabu H, Gao W, Dupuis J, Latourelle JC, Nishino M, Zazueta OE, Kurugol S, Ross JC, San José Estépar R, Schwartz DA, Rosas IO, Washko GR, O'Connor GT, Hunninghake GM. Development and Progression of Interstitial Lung Abnormalities in the Framingham Heart Study. Am J Respir Crit Care Med 2016;194:1514-22. [PMID: 27314401 DOI: 10.1164/rccm.201512-2523OC] [Cited by in Crossref: 134] [Cited by in F6Publishing: 74] [Article Influence: 26.8] [Reference Citation Analysis]
41 Hida T, Hata A, Lu J, Valtchinov VI, Hino T, Nishino M, Honda H, Tomiyama N, Christiani DC, Hatabu H. Interstitial lung abnormalities in patients with stage I non-small cell lung cancer are associated with shorter overall survival: the Boston lung cancer study. Cancer Imaging 2021;21:14. [PMID: 33468255 DOI: 10.1186/s40644-021-00383-w] [Reference Citation Analysis]
42 Miller ER, Putman RK, Vivero M, Hung Y, Araki T, Nishino M, Washko GR, Rosas IO, Hatabu H, Sholl LM, Hunninghake GM. Histopathology of Interstitial Lung Abnormalities in the Context of Lung Nodule Resections. Am J Respir Crit Care Med 2018;197:955-8. [PMID: 28934558 DOI: 10.1164/rccm.201708-1679LE] [Cited by in Crossref: 44] [Cited by in F6Publishing: 22] [Article Influence: 14.7] [Reference Citation Analysis]
43 Sack C, Vedal S, Sheppard L, Raghu G, Barr RG, Podolanczuk A, Doney B, Hoffman EA, Gassett A, Hinckley-Stukovsky K, Williams K, Kawut S, Lederer DJ, Kaufman JD. Air pollution and subclinical interstitial lung disease: the Multi-Ethnic Study of Atherosclerosis (MESA) air-lung study. Eur Respir J 2017;50:1700559. [PMID: 29217611 DOI: 10.1183/13993003.00559-2017] [Cited by in Crossref: 48] [Cited by in F6Publishing: 41] [Article Influence: 9.6] [Reference Citation Analysis]
44 Walsh SLF, Richeldi L. Subclinical Interstitial Lung Abnormalities: Lumping and Splitting Revisited. Am J Respir Crit Care Med 2019;200:121-3. [PMID: 30699307 DOI: 10.1164/rccm.201901-0180ED] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
45 Schupp JC, Kaminski N. Toward Early Detection of Idiopathic Pulmonary Fibrosis. Am J Respir Crit Care Med 2019;200:1339-40. [PMID: 31412723 DOI: 10.1164/rccm.201908-1530ED] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
46 Kliment CR, Araki T, Doyle TJ, Gao W, Dupuis J, Latourelle JC, Zazueta OE, Fernandez IE, Nishino M, Okajima Y, Ross JC, Estépar RS, Diaz AA, Lederer DJ, Schwartz DA, Silverman EK, Rosas IO, Washko GR, O'Connor GT, Hatabu H, Hunninghake GM. A comparison of visual and quantitative methods to identify interstitial lung abnormalities. BMC Pulm Med 2015;15:134. [PMID: 26514822 DOI: 10.1186/s12890-015-0124-x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 3.3] [Reference Citation Analysis]
47 Wells AU, Maher TM. Update in Interstitial Lung Disease 2016. Am J Respir Crit Care Med 2017;196:132-8. [PMID: 28530124 DOI: 10.1164/rccm.201702-0351UP] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 1.2] [Reference Citation Analysis]
48 Rosas IO, Dellaripa PF, Lederer DJ, Khanna D, Young LR, Martinez FJ. Interstitial lung disease: NHLBI Workshop on the Primary Prevention of Chronic Lung Diseases. Ann Am Thorac Soc 2014;11 Suppl 3:S169-77. [PMID: 24754826 DOI: 10.1513/AnnalsATS.201312-429LD] [Cited by in Crossref: 31] [Cited by in F6Publishing: 17] [Article Influence: 4.4] [Reference Citation Analysis]
49 Bhatt SP, Washko GR, Hoffman EA, Newell JD Jr, Bodduluri S, Diaz AA, Galban CJ, Silverman EK, San José Estépar R, Lynch DA. Imaging Advances in Chronic Obstructive Pulmonary Disease. Insights from the Genetic Epidemiology of Chronic Obstructive Pulmonary Disease (COPDGene) Study. Am J Respir Crit Care Med 2019;199:286-301. [PMID: 30304637 DOI: 10.1164/rccm.201807-1351SO] [Cited by in Crossref: 32] [Cited by in F6Publishing: 23] [Article Influence: 10.7] [Reference Citation Analysis]
50 Tan Y, Jia D, Lin Z, Guo B, He B, Lu C, Xiao C, Liu Z, Zhao N, Bian Z, Zhang G, Zhang W, Liu X, Lu A. Potential Metabolic Biomarkers to Identify Interstitial Lung Abnormalities. Int J Mol Sci 2016;17:E1148. [PMID: 27438829 DOI: 10.3390/ijms17071148] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
51 Doyle TJ, Hunninghake GM, Rosas IO. Subclinical interstitial lung disease: why you should care. Am J Respir Crit Care Med 2012;185:1147-53. [PMID: 22366047 DOI: 10.1164/rccm.201108-1420PP] [Cited by in Crossref: 92] [Cited by in F6Publishing: 50] [Article Influence: 9.2] [Reference Citation Analysis]
52 Nishino M, Cardarella S, Dahlberg SE, Araki T, Lydon C, Jackman DM, Rabin MS, Hatabu H, Johnson BE. Interstitial lung abnormalities in treatment-naïve advanced non-small-cell lung cancer patients are associated with shorter survival. Eur J Radiol 2015;84:998-1004. [PMID: 25726730 DOI: 10.1016/j.ejrad.2015.01.021] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 4.1] [Reference Citation Analysis]